Using light and algae to create valuable natural products
Harnessing light and model endosymbiosis to produce natural products
['FUNDING_R01'] · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · NIH-10876403
This study is exploring a new way to make important medicines, like antibiotics and cancer treatments, by using a friendly partnership between yeast and a type of bacteria that uses sunlight, which could lead to better and greener options for patients in the future.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN (nih funded) |
| Locations | 1 site (CHAMPAIGN, UNITED STATES) |
| Trial ID | NIH-10876403 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a sustainable method to produce important drugs and pharmaceuticals by combining the abilities of yeast and cyanobacteria. By harnessing light energy through photosynthesis, the cyanobacteria will provide essential nutrients to yeast cells, which will then use these resources to synthesize valuable natural products like antibiotics and anticancer agents. This innovative approach aims to create a more efficient and environmentally friendly production platform for these critical compounds. Patients may benefit from new and improved treatments derived from this biotechnological advancement.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals in need of antibiotics or anticancer treatments.
Not a fit: Patients who are not affected by bacterial infections or cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, sustainable sources of essential medications for patients.
How similar studies have performed: Other research has shown promise in using similar biotechnological approaches to produce natural products, indicating potential for success in this area.
Where this research is happening
CHAMPAIGN, UNITED STATES
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN — CHAMPAIGN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MEHTA, ANGAD — UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
- Study coordinator: MEHTA, ANGAD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents